Update information

Update information

August 2016 : A footnote was added to recommendation 1.7.1 about which proton pump inhibitors and H2-receptor antagonists are licensed for use and which are classed as off-label.

April 2015: Recommendation 1.2.5 has been amended to add the use of cryoprecipitate as further treatment.

ISBN: 978-1-4731-2041-9

  • National Institute for Health and Care Excellence (NICE)